A Phase 2 Study of SBRT for Squamous Cell Carcinoma of the Head and Neck
To evaluate the tumour response rate of squamous cell carcinoma of the head and neck following stereotactic body radiation therapy (SBRT) of 45Gy in 5 fractions delivered once every 3-4 days, such that treatment is completed within 15 days.
Primary Outcome:
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the Canadian Cancer Society